Dermatology · Sherman, TX
NPI
1578726352
Since 2008
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
815 Pecan Grove Rd E
Sherman, TX, 75090
Phone (903) 892-2126
Groups this clinician bills Medicare through
Medicare paid, 2024
$627K
11,216 services
Medicare patients, 2024
2,101
Average age 77
Drug cost, 2024
$1.4M
1,846 prescriptions
Company payments, 2025
$1,515
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Clint C Moss was code 17003 (destruction skin lesion), 4,640 times for 737 patients. In total Clint C Moss billed 11,216 services in 85 codes, and Medicare paid $627K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-07-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 4,640 | 737 | $4.93 | $23K |
| 99213 Office E&M - Established | Office | 2,232 | 1,642 | $63.84 | $142K |
| 17000 Destruction Skin Lesion | Office | 1,250 | 913 | $37.76 | $47K |
| 17110 Destruction Skin Lesion | Office | 895 | 757 | $79.61 | $71K |
| 11102 Skin Biopsy | Office | 368 | 325 | $60.25 | $22K |
| 17311 Mohs Surgery | Office | 257 | 216 | $510.54 | $131K |
| 99214 Office E&M - Established | Office | 239 | 202 | $92.01 | $22K |
| 99203 Office E&M - New | Office | 182 | 182 | $71.37 | $13K |
| 17004 Destruction Skin Lesion | Office | 113 | 89 | $115.27 | $13K |
| 12052 Wound Repair - All Levels | Office | 95 | 92 | $129.97 | $12K |
| 11103 Skin Biopsy | Office | 75 | 54 | $38.56 | $2,892 |
| 17111 Destruction Skin Lesion | Office | 70 | 62 | $90.13 | $6,309 |
| 17312 Mohs Surgery | Office | 69 | 53 | $335.48 | $23K |
| 17281 Destruction Skin Lesion | Office | 57 | 46 | $121.57 | $6,929 |
| 12032 Wound Repair - All Levels | Office | 54 | 51 | $193.44 | $10K |
By year: 2022 $589K for 12,198 services; 2023 $561K for 11,480 services; 2024 $627K for 11,216 services.
Medicare prescription drug claims, 2024
In 2024, the drug Clint C Moss prescribed most often to Medicare patients was Clobetasol Propionate, with 330 prescriptions and refills. In total Clint C Moss wrote 1,846 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 330 | 375 | 192 | $16K |
| Triamcinolone Acetonide Generic | 286 | 315 | 195 | $3,546 |
| Doxycycline Monohydrate Generic | 154 | 169 | 60 | $5,363 |
| Ketoconazole Generic | 117 | 129 | 51 | $1,861 |
| Hydrocortisone Generic | 110 | 114 | 74 | $517 |
| Fluorouracil Generic | 66 | 66 | 60 | $3,649 |
| Minoxidil Generic | 64 | 163 | 26 | $1,029 |
| Valacyclovir Valacyclovir Hcl | 57 | 77 | 24 | $1,149 |
| Cephalexin Generic | 56 | 56 | 53 | $174 |
| Metronidazole Generic | 49 | 61 | 27 | $2,648 |
| Tremfya Guselkumab | 46 | 87 | Under 11 | $641K |
| Doxycycline Hyclate Generic | 41 | 42 | 16 | $906 |
| Dupixent Pen Dupilumab | 37 | 37 | Under 11 | $142K |
| Minocycline Hcl Generic | 34 | 34 | Under 11 | $1,243 |
| Otezla Apremilast | 33 | 33 | Under 11 | $159K |
Brand drugs: 159 claims; generic drugs: 1,687 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Clint C Moss $1,515 ($1,515 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $392.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 24 | $392 |
| LEO Pharma Inc. | 10 | $248 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $233 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 7 | $156 |
| UCB, Inc. UCB.BR | 3 | $84.12 |
| Janssen Biotech, Inc. JNJ | 3 | $81.21 |
| Galderma Laboratories, L.P. GALD.SW | 5 | $71.86 |
| Lilly USA, LLC LLY | 3 | $71.23 |
| Pfizer Inc. PFE | 3 | $46.49 |
| Botanix SB Inc | 2 | $36.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.